Related Experiment Video
Updated: Dec 13, 2025
06:08
A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
24.0K
Cardiomyopathies and Adrenal Diseases
Luigi Petramala1, Antonio Concistrè1, Federica Olmati1
1Department of Translational and Precision Medicine, Sapienza University of Rome, 00185 Roma, Italy.
International Journal of Molecular Sciences
|July 26, 2020
Summary
Endomyocardial biopsy (EMB) is a safe and valuable tool for diagnosing cardiomyopathies caused by adrenal diseases like primary aldosteronism, Cushing's syndrome, and pheochromocytoma. EMB reveals specific microscopic changes, aiding in understanding and managing these complex heart conditions.
Area of Science:
- Cardiology
- Endocrinology
- Pathology
Background:
- Cardiomyopathies involve structural/functional heart muscle abnormalities.
- Adrenal diseases (hyperaldosteronism, hypercortisolism, hypercatecholaminism) were previously misunderstood causes of cardiomyocyte disorders.
- Endomyocardial biopsy (EMB) was historically deemed too invasive, hindering diagnosis.
Purpose of the Study:
- To review the role of EMB in diagnosing cardiomyopathies associated with adrenal diseases.
- To highlight key microscopic and ultrastructural findings from recent EMB studies.
- To emphasize EMB as a safe and informative diagnostic tool.
Main Methods:
- Review of recent endomyocardial biopsy (EMB) studies.
- Analysis of histopathological and ultrastructural features in patients with adrenal diseases and cardiomyopathies.
- Focus on primary aldosteronism (PA), Cushing's syndrome (CS), and pheochromocytoma (PHEO).
Main Results:
- Primary aldosteronism (PA): Aldosterone excess causes ion/water imbalance, vacuolization, swelling, and potential interstitial edema.
- Cushing's syndrome (CS): Characterized by cardiomyocyte hypertrophy and myofibrillolysis, linked to increased atrogin-1 expression.
- Pheochromocytoma (PHEO): Shows myofilament hypercontraction, contraction bands, and occasional necrosis.
Conclusions:
- Endomyocardial biopsy (EMB) is a safe and effective technique when performed in experienced centers.
- EMB provides crucial insights into the physiopathological mechanisms of cardiomyopathies linked to adrenal disorders.
- EMB can guide new management strategies and therapies for these conditions.
Related Concept Videos
01:27Adrenal Gland Disorders
2.7K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
2.7K
01:25Cardiomyopathy I: Introduction and Classification
361
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
361
01:30Cardiomyopathy II: Dilated Cardiomyopathy
293
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
293
01:29Cardiomyopathy V: Interprofessional Care
196
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
196
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
248
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
248
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
322
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
322